Implementation of AMR policy and decision-making should be guided only by reliable, unbiased estimates of effect size. Generating these estimates requires a thorough understanding of important biases and their impact on measured outcomes.
All stakeholders are now invited to provide written feedback on the draft IACG recommendations.
A few years ago my neighbor urgently had to be hospitalized. He was suffering from a serious infection, lost consciousness and was treated with various antibiotics at the intensive care unit. These antibiotics did not work, one after the other. After a week, my neighbor died from the consequences of the infectious disease. Other than going to his cremation I could not say goodbye. Antibiotic resistance was suddenly the reality of the next door neighbor and no longer an abstract concept and just a topic at work.
The Dag Hammarskjold Foundation and ReAct – Action on Antibiotic Resistance hosted a meeting to discuss how AMR could become more visible and how more funds to tackle AMR could be mobilized. Download the report!
Selected entrants will receive $100,000 to further develop and test prototypes to improve detection of drug-resistant bacteria or differentiate between a bacterial and viral infection.